• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

膀胱癌的病因。

Etiology of bladder cancer.

作者信息

Shirai T

机构信息

First Department of Pathology, Nagoya City University Medical School, Japan.

出版信息

Semin Urol. 1993 Aug;11(3):113-26.

PMID:8210833
Abstract

That the etiology of bladder cancer involves environmental factors is well documented. Most chemical carcinogens probably affect the urothelial cells via their presence in the urine. As an important cofactor, cell-proliferative activity may be increased by urinary bladder infection, irritation by bladder stones or through the action of a variety of direct acting chemicals or agents. Among the known causative factors, avoidable major ones are occupational exposure to certain chemicals such as benzidine and 4-aminobiphenyl, cigarette smoking, and bilharzial infection, which could be eradicated by a combination of praziquantel, antihelminth therapy, education, and improvements in social welfare. An anticarcinogenic drug, cyclophosphamide, used as an immunosuppressive agent also seems to be associated with a high risk of idiopathic induction of bladder cancer and physicians should therefore pay particular attention to its diverse effects when considering its prescription. In contrast to the above, the consumption of coffee and tea containing artificial sweeteners is now thought unlikely to be a major risk. So far there is no good biochemical tool to predict individual exposure to bladder carcinogens/or relative risk of bladder-cancer development. However, acetylation capacity can be applied to assess susceptibility to carcinogenic amines in people exposed in their working environment. Progress in molecular-biological analysis will hopefully bring to light etiology-specific DNA damage in bladder tumors, and it may prove useful for prediction of tumor behavior in the near future.

摘要

膀胱癌的病因涉及环境因素,这一点已有充分的文献记载。大多数化学致癌物可能通过存在于尿液中而影响尿路上皮细胞。作为一个重要的辅助因素,膀胱感染、膀胱结石刺激或各种直接作用的化学物质或制剂的作用可能会增加细胞增殖活性。在已知的致病因素中,可避免的主要因素是职业接触某些化学物质,如联苯胺和4-氨基联苯、吸烟以及血吸虫感染,通过吡喹酮、抗蠕虫治疗、教育和社会福利改善相结合的方式可以根除这些因素。一种用作免疫抑制剂的抗癌药物环磷酰胺似乎也与特发性诱发膀胱癌的高风险有关,因此医生在考虑开这种药时应特别注意其多种影响。与上述情况相反,现在认为饮用含人工甜味剂的咖啡和茶不太可能是主要风险。到目前为止,还没有很好的生化工具来预测个体接触膀胱致癌物的情况或膀胱癌发生的相对风险。然而,乙酰化能力可用于评估在工作环境中接触致癌物的人群对致癌胺的易感性。分子生物学分析的进展有望揭示膀胱肿瘤中病因特异性的DNA损伤,并且在不久的将来可能被证明对预测肿瘤行为有用。

相似文献

1
Etiology of bladder cancer.膀胱癌的病因。
Semin Urol. 1993 Aug;11(3):113-26.
2
The etiology of bladder cancer--are there any new clues or predictors of behavior?
Int J Urol. 1995 Jun;2 Suppl 2:64-75. doi: 10.1111/j.1442-2042.1995.tb00481.x.
3
Mechanisms of disease: The epidemiology of bladder cancer.疾病机制:膀胱癌的流行病学
Nat Clin Pract Urol. 2006 Jun;3(6):327-40. doi: 10.1038/ncpuro0510.
4
Epidemiology and etiology of bladder cancer.膀胱癌的流行病学与病因学
Urol Clin North Am. 1992 Aug;19(3):421-8.
5
Occupational exposure to chemical and petrochemical industries and bladder cancer risk in four western Canadian provinces.加拿大西部四个省份化学和石化行业的职业暴露与膀胱癌风险
Chronic Dis Can. 2004 Spring;25(2):7-15.
6
Epidemiological models of carcinogenesis: the example of bladder cancer.致癌作用的流行病学模型:以膀胱癌为例。
Cancer Epidemiol Biomarkers Prev. 1992 Jan-Feb;1(2):149-53.
7
Bladder cancer epidemiology and pathogenesis.膀胱癌的流行病学与发病机制。
Semin Oncol. 1996 Oct;23(5):536-45.
8
Nonsmoking-related arylamine exposure and bladder cancer risk.与非吸烟相关的芳胺暴露与膀胱癌风险
Cancer Epidemiol Biomarkers Prev. 2003 Jun;12(6):503-7.
9
Environmental and chemical carcinogenesis.环境与化学致癌作用
Semin Cancer Biol. 2004 Dec;14(6):473-86. doi: 10.1016/j.semcancer.2004.06.010.
10
[Individual susceptibility to occupational carcinogens: the evidence from biomonitoring and molecular epidemiology studies].[个体对职业致癌物的易感性:来自生物监测和分子流行病学研究的证据]
G Ital Med Lav Ergon. 2004 Oct-Dec;26(4):311-21.

引用本文的文献

1
Relationship among DDR gene mutations, TMB and PD-L1 in solid tumour genomes identified using clinically actionable biomarker assays.使用临床可操作生物标志物检测方法鉴定的实体瘤基因组中DDR基因突变、肿瘤突变负荷(TMB)和程序性死亡受体配体1(PD-L1)之间的关系。
NPJ Precis Oncol. 2023 Oct 11;7(1):103. doi: 10.1038/s41698-023-00442-4.
2
Role of ERK signaling in bladder urothelium in response to cyclophosphamide injury.丝裂原活化蛋白激酶(ERK)信号通路在环磷酰胺损伤膀胱尿路上皮中的作用。
Physiol Rep. 2022 Jul;10(14). doi: 10.14814/phy2.15378.
3
Durability of and role of AKT in FGF7p urothelial protection against cyclophosphamide.
AKT 在 FGF7p 尿路上皮对抗环磷酰胺中的耐久性和作用。
Physiol Rep. 2022 Jun;10(12):e15358. doi: 10.14814/phy2.15358.
4
FGF7 peptide (FGF7p) mimetic mitigates bladder urothelial injury from cyclophosphamide.成纤维细胞生长因子 7 肽(FGF7p)模拟物减轻环磷酰胺引起的膀胱尿路上皮损伤。
Physiol Rep. 2022 Apr;10(7):e15241. doi: 10.14814/phy2.15241.
5
AKT Signaling Downstream of KGF Is Necessary and Sufficient for Blocking Cyclophosphamide Bladder Injury.KGF 下游的 AKT 信号通路的阻断对于抑制环磷酰胺诱导的膀胱损伤是必要且充分的。
Am J Pathol. 2022 Apr;192(4):604-612. doi: 10.1016/j.ajpath.2022.01.004. Epub 2022 Jan 19.
6
Loss of Fibroblast Growth Factor Receptor 2 (FGFR2) Leads to Defective Bladder Urothelial Regeneration after Cyclophosphamide Injury.成纤维细胞生长因子受体 2(FGFR2)缺失导致环磷酰胺损伤后膀胱尿路上皮再生缺陷。
Am J Pathol. 2021 Apr;191(4):631-651. doi: 10.1016/j.ajpath.2020.12.011. Epub 2020 Dec 30.
7
Keratinocyte Growth Factor Reduces Injury and Leads to Early Recovery from Cyclophosphamide Bladder Injury.角质细胞生长因子减少环磷酰胺膀胱损伤并促进早期恢复。
Am J Pathol. 2020 Jan;190(1):108-124. doi: 10.1016/j.ajpath.2019.09.015. Epub 2019 Oct 22.
8
Mapping of the UGT1A locus identifies an uncommon coding variant that affects mRNA expression and protects from bladder cancer.UGT1A 基因座的定位鉴定出一种罕见的编码变异,它影响 mRNA 表达并预防膀胱癌。
Hum Mol Genet. 2012 Apr 15;21(8):1918-30. doi: 10.1093/hmg/ddr619. Epub 2012 Jan 6.
9
Levels of certain tumor markers as differential factors between bilharzial and non-biharzial bladder cancer among Egyptian patients.某些肿瘤标志物水平作为埃及患者埃及血吸虫性膀胱癌与非埃及血吸虫性膀胱癌的鉴别因素。
Cancer Cell Int. 2011 Apr 7;11(1):8. doi: 10.1186/1475-2867-11-8.
10
Human epididymis protein 4 is a biomarker for transitional cell carcinoma in the urinary system.人附睾蛋白 4 是泌尿系统移行细胞癌的一种生物标志物。
J Clin Lab Anal. 2009;23(6):357-61. doi: 10.1002/jcla.20329.